NORTHERN TRUST CORP - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,685,802
-25.0%
485,822
+0.6%
0.00%
Q2 2023$2,246,285
+6.9%
483,072
+6.2%
0.00%
Q1 2023$2,101,671
-43.5%
454,907
-1.2%
0.00%
-100.0%
Q4 2022$3,721,349
+64.8%
460,563
+13.2%
0.00%0.0%
Q3 2022$2,258,000
+15.0%
406,772
+7.9%
0.00%
Q2 2022$1,964,000
-38.9%
376,980
-3.6%
0.00%
-100.0%
Q1 2022$3,214,000
-60.4%
391,024
-28.3%
0.00%0.0%
Q4 2021$8,112,000
-19.9%
545,224
+1.7%
0.00%
-50.0%
Q3 2021$10,126,000
-1.7%
536,024
-3.3%
0.00%0.0%
Q2 2021$10,306,000
+31.5%
554,399
+61.0%
0.00%
+100.0%
Q1 2021$7,837,000
+14.9%
344,321
+9.6%
0.00%0.0%
Q4 2020$6,822,000
+207.4%
314,276
+42.3%
0.00%
Q3 2020$2,219,000
+30.5%
220,809
+0.8%
0.00%
Q2 2020$1,701,000
+30.6%
219,150
+71.6%
0.00%
Q1 2020$1,302,000
-3.1%
127,682
+4.5%
0.00%
Q4 2019$1,344,000
+21.8%
122,180
+0.6%
0.00%
Q3 2019$1,103,000
+21.6%
121,424
+52.2%
0.00%
Q2 2019$907,000
+6.5%
79,777
+6.6%
0.00%
Q1 2019$852,000
+46.9%
74,867
+16.4%
0.00%
Q4 2018$580,00064,3160.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders